abstract |
The present invention provides modulators for the RORγ nuclear orphan receptor and methods for treating RORγ-mediated diseases by introducing said new RORγ modulators to a human or mammal in need of said treatment. In particular, the present invention provides cyclic compounds containing a carboxamide of the formulas (1) to (5) enantiomers, diastereomers, tautomers, N-oxides, solvates and pharmaceutically acceptable salts of these compounds. |